Cargando…

Reporting quality of abstracts in phase III clinical trials of systemic therapy in metastatic solid malignancies

BACKGROUND: Manuscript abstracts represent a critical source of information for oncology practitioners. Practitioners may utilize the information contained in abstracts as a basis for treatment decisions particularly when full-text articles are not accessible. In 2007, the Consolidated Standards of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sivendran, Shanthi, Newport, Kristina, Horst, Michael, Albert, Adam, Galsky, Matthew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545856/ https://www.ncbi.nlm.nih.gov/pubmed/26253548 http://dx.doi.org/10.1186/s13063-015-0885-9

Ejemplares similares

Ring chromosome 18 abnormality in acute myelogenous leukemia: the clinical dilemma
por: Sivendran, Shanthi, et al.
Publicado: (2010)

Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2016)

Metastatic malignant solid pseudopapillary tumor of the pancreas
por: Kim, Jun Jae, et al.
Publicado: (2013)

Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies
por: Yao, Shuyang, et al.
Publicado: (2021)

A phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors
por: Cohen, Adam L., et al.
Publicado: (2016)

Factors associated with successful phase III trials for solid tumors: A systematic review
por: Otsuka, Yasushi, et al.
Publicado: (2021)

A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours
por: Maity, Amit, et al.
Publicado: (2018)

Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Liaw, Bobby C, et al.
Publicado: (2022)

Associations between safety, tolerability, and toxicity and the reporting of health‐related quality of life in phase III randomized trials in common solid tumors
por: Saleh, Ramy R., et al.
Publicado: (2020)

The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov
por: Que, Y, et al.
Publicado: (2018)

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies
por: Rixe, Olivier, et al.
Publicado: (2015)

Solid Phase Extraction for Monitoring of Occupational Exposure to Cr (III)
por: Shahtaheri, S.J., et al.
Publicado: (2007)

Radiation strategy and techniques for metastatic pleural disease from thymic malignancies: extended abstract
por: Shepherd, Annemarie F., et al.
Publicado: (2022)

Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors
por: Yao, Shuyang, et al.
Publicado: (2021)

Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer
por: Belfiglio, Maurizio, et al.
Publicado: (2011)

Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
por: Gulley, James L., et al.
Publicado: (2019)

Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials
por: Wells, J Connor, et al.
Publicado: (2022)

Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies
por: Kunos, Charles A., et al.
Publicado: (2012)

Same/Different Abstract Concept Learning by Archerfish (Toxotes chatareus)
por: Newport, Cait, et al.
Publicado: (2015)

Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies
por: Reed, Damon R., et al.
Publicado: (2015)

Guselkumab for the Treatment of Psoriasis: A Review of Phase III Trials
por: Nakamura, Mio, et al.
Publicado: (2017)

DNA Display III. Solid-Phase Organic Synthesis on Unprotected DNA
por: Halpin, David R, et al.
Publicado: (2004)

Phase I Trial of Triapine–Cisplatin–Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers
por: Kunos, Charles A., et al.
Publicado: (2017)

Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial
por: Lorentzen, Cathrine Lund, et al.
Publicado: (2022)

Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials
por: Farahnik, Benjamin, et al.
Publicado: (2016)

Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials
por: Farahnik, Benjamin, et al.
Publicado: (2016)

Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
por: Keilholz, Ulrich, et al.
Publicado: (2019)

Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP
por: Stockler, Martin R., et al.
Publicado: (2022)

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
por: Heiss, Markus M, et al.
Publicado: (2010)

Abstract 8 Health-Related Quality of Life (HRQL) Following Transplantation with Omidubicel Versus Umbilical Cord Blood (UCB) in Patients with Hematologic Malignancies: Results from a Phase III Randomized, Multicenter Study
por: Lin, Chenyu, et al.
Publicado: (2022)

Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial
por: Cella, D, et al.
Publicado: (2013)

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations
por: Yoshino, Takayuki, et al.
Publicado: (2014)

Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review
por: Komorowski, Adam S., et al.
Publicado: (2020)

A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens
por: Phillips, Patrick P. J., et al.
Publicado: (2017)

Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites
por: Ott, Marion G, et al.
Publicado: (2012)

A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent
por: Sharma, Padmanee, et al.
Publicado: (2015)

The Influence of Metastatic Lymph Node Ratio on the Treatment Outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Trial: A Phase III Trial
por: Kim, Youjin, et al.
Publicado: (2016)

Metastatic malignancy masquerading as neurocysticercosis
por: DiMarco, Daniela E., et al.
Publicado: (2019)

Quarterly Abstracts of Papers on the Diseases of Children.—No. III
por: Chapman, J. Milne
Publicado: (1883)

Solid-to-solid polymorphic phase transitions in two isostructural Bi(III) complexes with 1-phenylethyl-N-ethylthiosemicarbazide and halogens
por: Grześkiewicz, Anita M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ult7vb6c5tcfc7olafn8gt1pb2